✦ LIBER ✦

Evaluation of CA 125 as a serum marker of hepatocellular carcinoma

✍ Scribed by John Elias; Michael C. Kew

Publisher: John Wiley and Sons
Year: 1990
Tongue: French
Weight: 331 KB
Volume: 46
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910460510

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Serum CA 125 concentrations were raised in 90.4% of 115 southern African black patients with hepatocellular carcinoma. Seventy‐four percent of 62 patients with amebic hepatic abscess, 60% of 40 patients with chronic hepatic parenchymal disease (chronic hepatitis or cirrhosis), and 60.9% of 41 patients with acute viral hepatitis also had raised values. The median serum CA 125 concentration for patients with hepatocellular carcinoma differed significantly from the benign hepatic disease groups analysed (p < 0.0002). Serum alphafetoprotein levels were raised in 90.4% of the 115 hepatocellular carcinoma patients. CA 125 is thus a highly sensitive marker for hepatocellular carcinoma, but lacks specificity.

📜 SIMILAR VOLUMES

Evaluation of serum ca 125 as a tumor ma

Evaluation of serum ca 125 as a tumor marker in non-small cell lung cancer

✍ Dr. M. Diez; F. J. Cerdàn; M. D. Ortega; A. Torres; A. Picardo; J. L. Balibrea 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

Serum C-reactive protein as a serum mark

Serum C-reactive protein as a serum marker for the diagnosis of hepatocellular carcinoma

✍ Fa-Yauh Lee; Shou-Dong Lee; Yang-Te Tsai; Jaw-Ching Wu; Kwok-Hung Lai; Kwang-Jue 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 2 views

Evaluation of des-γ-carboxy prothrombin

Evaluation of des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma

✍ Yoshihiro Deyashiki; Yoshimi Nishioka; Katsumi Takahashi; Yoshitane Kosaka; Koji 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

Serum transforming growth factor α level

Serum transforming growth factor α level as a marker of hepatocellular carcinoma complicating cirrhosis

✍ Tomoaki Tomiya; Kenji Fujiwara 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 1 views

Transforming growth factor u (TGFn) is alleged to play a role in malignant progression as well as normal cell growth in an autocrine manner and its serum levels have been reported to increase during this progression. Most hepatocellular carcinomas (HCC) develop in cirrhotic livers in which hepatocyt

Serum CA 125 level as a predictor of per

Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma

✍ Bunzo Nakata; Kosei Hirakawa-YS Chung; Yasuyuki Kato; Yoshito Yamashita; Kiyoshi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. Prediction of peritoneal dissemination is very difficult using current diagnostic tools such as computed tomography, ultrasonography, or various tumor markers. The predictive value of serum CA 125 levels for peritoneal metastasis from gastric carcinoma was studied. ## METHODS. Th

Evaluation of five glycoprotein tumour m

Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma

✍ Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 53 KB 👁 1 views

Increased levels of glycoprotein tumour markers have been observed in sera of patients with renal-cell carcinoma. Five different glycoprotein markers [carcinoembryonic antigen (CEA), CA-50, CA-19-9, CA-125 and CA-15-3] were assessed in 154 consecutive patients with renal-cell carcinoma before initia